Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1213 ARTÍCULOS , VIENDO DEL 1006 AL 1020

Regulation of neurotropic signaling by the inducible, NF-kB-sensitive miRNA-125b in Alzheimer's disease (AD) and in primary human neuronal-glial (HNG) cells

Zhao Y, Bhattacharjee S, Jones BM, Hill J, Dua P, Lukiw WJ.

Mol Neurobiol. 2014 Aug;50(1):97-106. doi: 10.1007/s12035-013-8595-3. Epub 2013 Nov 29.

[Does gender really affect the socio-economic characteristics of the primary caregiver in Alzheimer's disease?]

Ruiz-Adame Reina M, González-Camacho MC, Mainar Causapé A.

Gac Sanit. 2014 May-Jun;28(3):258. doi: 10.1016/j.gaceta.2013.09.004. Epub 2013 Dec 2.

Potential novel targets for Alzheimer pharmacotherapy: II. Update on secretase inhibitors and related approaches

Mikulca JA, Nguyen V, Gajdosik DA, Teklu SG, Giunta EA, Lessa EA, Tran CH, Terak EC, Raffa RB.

J Clin Pharm Ther. 2014 Feb;39(1):25-37. doi: 10.1111/jcpt.12112. Epub 2013 Dec 8.

MAM (mitochondria-associated membranes) in mammalian cells: lipids and beyond

Vance JE.

Biochim Biophys Acta. 2014 Apr 4;1841(4):595-609. doi: 10.1016/j.bbalip.2013.11.014. Epub 2013 Dec 6.

Calcium channelopathies and Alzheimer's disease: insight into therapeutic success and failures

Chakroborty S, Stutzmann GE.

Eur J Pharmacol. 2014 Sep 15;739:83-95. doi: 10.1016/j.ejphar.2013.11.012. Epub 2013 Dec 6.

A small molecule that displays marked reactivity toward copper- versus zinc-amyloid-β implicated in Alzheimer's disease

Savelieff MG, Liu Y, Senthamarai RR, Korshavn KJ, Lee HJ, Ramamoorthy A, Lim MH.

Chem Commun (Camb). 2014 May 25;50(40):5301-3. doi: 10.1039/c3cc48473d. Epub 2013 Dec 10.

Absence of amyloid-beta in lenses of Alzheimer patients: a confocal Raman microspectroscopic study

Michael R, Otto C, Lenferink A, Gelpi E, Montenegro GA, Rosandić J, Tresserra F, Barraquer RI, Vrensen GF.

Exp Eye Res. 2014 Feb;119:44-53. doi: 10.1016/j.exer.2013.11.016. Epub 2013 Dec 12.

Abnormal kalirin signaling in neuropsychiatric disorders

Remmers C, Sweet RA, Penzes P.

Brain Res Bull. 2014 Apr;103:29-38. doi: 10.1016/j.brainresbull.2013.12.006. Epub 2013 Dec 12.

Early differences in dorsal hippocampal metabolite levels in males but not females in a transgenic rat model of Alzheimer's disease

Nilsen LH, Melø TM, Witter MP, Sonnewald U.

Neurochem Res. 2014 Feb;39(2):305-12. doi: 10.1007/s11064-013-1222-x. Epub 2013 Dec 17.

Novel tacrine analogs as potential cholinesterase inhibitors in Alzheimer's disease

El-Malah A, Gedawy EM, Kassab AE, Salam RM.

Arch Pharm (Weinheim). 2014 Feb;347(2):96-103. doi: 10.1002/ardp.201300121. Epub 2013 Dec 16.

Clusterin in Alzheimer's disease: a player in the biological behavior of amyloid-beta

Li X, Ma Y, Wei X, Li Y, Wu H, Zhuang J, Zhao Z.

Neurosci Bull. 2014 Feb;30(1):162-8. doi: 10.1007/s12264-013-1391-2. Epub 2013 Dec 19.

Electronic organiser and Alzheimer's disease: fact or fiction?

Imbeault H, Bier N, Pigot H, Gagnon L, Marcotte N, Fulop T, Giroux S.

Neuropsychol Rehabil. 2014;24(1):71-100. doi: 10.1080/09602011.2013.858641. Epub 2013 Dec 23.

Tau-aggregation inhibitor therapy for Alzheimer's disease

Wischik CM, Harrington CR, Storey JM.

Biochem Pharmacol. 2014 Apr 15;88(4):529-39. doi: 10.1016/j.bcp.2013.12.008. Epub 2013 Dec 19.

A caregiver's wish list for a National Alzheimer's Agenda

Vann AS.

Am J Alzheimers Dis Other Demen. 2014 Mar;29(2):111-3. doi: 10.1177/1533317513511292. Epub 2013 Dec 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias